spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Nestlé 

 HSMN NewsFeed - 10 Jun 2021
Senda Biosciences Announces Closing of $98 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Nov 2020
Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Jun 2020
Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Devices Dermatology FDA
 HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 15 Oct 2018
Palette Life Sciences and Nestlé Skin Health Enter into Global Licensing Agreement for Deflux(R), Solesta(R) and Barrigel(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 May 2018
Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
Devices Dermatology FDA
 HSMN NewsFeed - 16 Jan 2018
Novartis new data reinforces superiority of Cosentyx(R) versus Stelara(R) in achieving skin clearance for psoriasis patients
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 4 Jan 2018
Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Jul 2017
Enterome and Nestlé Health Science Launch New Diagnostics Company
Diagnostics
 HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Jun 2017
Pharmavite Appoints Matthew Roberts to New Role of Executive Vice President, Chief Technical and Quality Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 30 Jan 2017
Ampersand Capital Partners and 1315 Capital to Acquire Genoptix
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2016
Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-derived Biomarkers, Drug Targets and Bioactive Molecules
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 3 Nov 2016
Enterome Appoints Christophe Bonny as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2016
Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep(R) Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso(R) Gel
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 20 Apr 2016
Enterome Raises EUR14.5 Million in Series C Financing Round
Biopharmaceuticals Gastroenterology Venture Capital
 HSMN NewsFeed - 31 Mar 2016
ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2015
Flagship Ventures Launches Rubius To Develop Red-Cell Therapeutics(TM)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2014
BIND Therapeutics Appoints Two New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Aug 2014
Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2014
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 7 Nov 2013
Pathway Genomics Names Robert C. Verfurth as Vice President of Sales
Diagnostics Personnel
 HSMN NewsFeed - 19 Sep 2013
Prometheus Laboratories Appoints Chief Executive Officer
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 24 Apr 2013
Teva Establishes Global Specialty Medicines Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2012
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Diagnostics Personnel Personalized Medicine
 HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Diagnostics Personalized Medicine Gastroenterology
 HSMN NewsFeed - 23 Apr 2012
Pfizer To Divest Nutrition Business To Nestlé
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Feb 2012
Prometheus Announces New Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 3 Jan 2012
Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Aug 2010
Celgene Corporation Announces Appointment of Jacqualyn A. Fouse as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 2 Jul 2009
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 3 Feb 2009
Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 15 Sep 2008
Alcon Launches New AcrySof(R) ReSTOR(R) Intraocular Lens for Presbyopia Outside the U.S.
Devices Ophthalmology
 HSMN NewsFeed - 12 Sep 2008
Alcon Expands Refractive Surgery Options with the Introduction of the AcrySof(R) Phakic Intraocular Lens Outside the U.S.
Devices Ophthalmology
 HSMN NewsFeed - 18 Aug 2008
Bausch & Lomb Names Presidents for Europe, Middle East, & Africa and Asia Pacific Regions
Devices Ophthalmology Personnel
 HSMN NewsFeed - 11 Jul 2008
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Jul 2008
Novartis Completes Purchase of Minority Interest in Alcon
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Jul 2008
Novartis completes acquisition of 25% stake in Alcon from Nestlé, first step toward majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 24 Jun 2008
Alcon Enters Into Patent Cross-Licensing Agreement With AMO
Devices Ophthalmology Licensing
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Synergetics USA, Inc. Initiates Antitrust Lawsuit against Alcon, Inc.
Devices Ophthalmology Litigation
 HSMN NewsFeed - 7 Apr 2008
Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2008
ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Mar 2008
Alcon Announces Leadership Change to Research and Development Organization
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2008
Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 6 Nov 2007
Alcon Gains All Regulatory Clearances for Acquisition of WaveLight AG
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2007
Bausch & Lomb Names Dipankar Bhattacharjee Corporate Vice President and President - Asia Pacific Region
Devices Ophthalmology Personnel
 HSMN NewsFeed - 28 Sep 2007
Alcon Gains 76.9 Percent of WaveLight Shares and Will Move Forward with Acquisition
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
Alcon Receives FDA Decision on RETAANE(R) Suspension for Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 10 Sep 2007
Alcon Waives Minimum Acceptance Condition for WaveLight AG
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2007
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 10 Sep 2007
Alcon Announces Expansion of Swiss Operations
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 24 Jul 2007
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 26 Jun 2007
Jacqualyn Fouse to Leave Alcon for New Position
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 20 Jun 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 12 Apr 2007
Novartis Completes Its Business Portfolio Restructuring, Divesting Gerber for USD 5.5 Billion to Nestlé
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2007
Galderma USA Introduces New Kit For Rosacea Treatment
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Nov 2006
Major Cyberonics Shareholders Demand Removal of Kevin Moore as Director and that He Return Fees and Stock Options Awarded While He Was Improperly Serving on Board
Devices Personnel
 HSMN NewsFeed - 7 Nov 2006
SkinMedica and Galderma to Co-Promote Desonate(TM)
Biopharmaceuticals Dermatology
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
Nestlé
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.